Skip to content

RNA BIOCLIN

Active Private limited companyfounded 2015active for 11 yearsAvenue des Sapins (N.) 27, 7020 MonsKBO/BCE: BE 0628.720.544

Board

1 director, since incorporation
Manager
since 20-04-2015 term without a fixed end
listed in the 2025 annual accounts, filed on 30-09-2026

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today

Manager
Board
Mandates as a list
    • Manager, from 20-04-2015 to date

Control

Shareholder
100%
This company
RNA BIOCLIN
Equity €175,530
Profit €90,311 in 2025

Capital

Contribution
€18,600
Shares
100
Contribution per share
€186
Equity per share
€1,755 in 2025
Source
2025 annual accounts

Articles of association

DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 16-02-2024 (in French)
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Tuesday of May
deed of 22-04-2015 (in French)

Capital transactions

Shareholders according to the deeds
At incorporation deed of 22-04-2015 ↗
  • 100 shares (100%) · €18,600
Capital over time
  1. 16-02-2024 Converted to unavailable equity · €20,460
  2. 22-04-2015 Incorporation · €18,600 · 100 shares

Next steps